Format

Send to

Choose Destination
See comment in PubMed Commons below
Exp Hematol Oncol. 2013 Jul 1;2(1):17. doi: 10.1186/2162-3619-2-17.

CD133: a stem cell biomarker and beyond.

Author information

  • 1Central Laboratory, the 10th People's Hospital, Tongji University, 301 Middle Yanchang Road, Shanghai 200072, China. lizhongsh@yahoo.com.

Abstract

Cancer stem cells (CSCs) or tumor initiating cells (TICs) contribute to tumorigenesis, metastasis, recurrence and chemoresistance. CD133, a pentaspan membrane glycoprotein, has been used as a stem cell biomarker for isolation of stem-like cells from a variety of normal and pathological tissues as well as cell lines since its discovery in 1999. Recent studies are focusing on the functionality of CD133. In this review, we summarize new insights into CD133 regulation and the involvement of CD133 in cell self-renewal, tumorigenesis, metastasis, resistance, metabolism, differentiation, autophagy, apoptosis, and regeneration.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk